A multicenter, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa delivered via a pump system as a continuous subcutaneous infusion in subjects with advanced Parkinson's Disease (UBeyoNDU)
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
NeuroDerm, Ltd
Start Date
June 15, 2017
End Date
February 8, 2018
Administered By
Neurology, Movement Disorders
Awarded By
NeuroDerm, Ltd
Start Date
June 15, 2017
End Date
February 8, 2018